Celltrion presents new twoyear data for subcutaneous inflixi

Celltrion today presented positive twoyear results from the extended LIBERTY studies LIBERTYCD1 and LIBERTYUC2 in patients with moderately to severely active Crohns disease CD and ulcerative colitis UC. Celltrion also presented endoscopic outcomes from the posthoc analysis of the LIBERTYCD study.3

Related Keywords

New York , United States , Incheon , Inch On Gwangyoksi , South Korea , Sweden , Brazil , Stockholm , United Kingdom , Australia , Taiwan , Canada , Brucee Sands , Nam Lee , Jeanf Colombel , Icahn School Of Medicine At Mount Sinai , Colitis Organisation , European Crohn , Icahn School , Mount Sinai , Medical Director , Celltrion Healthcare , Media Contact , Celltrion Jean Frdric Colombel Nam Lee Ecco Congress European Crohns And Colitis Organisation Liberty Studies Disease Cd Ulcerative Uc Libertycd Study Icahn School Of Medicine Ctp13 Sc Phase 3 Maintenance Therapy Inflammatory Bowel Ibd Endoscopic Posthoc Analysis ,